214 related articles for article (PubMed ID: 36064599)
1. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.
Baloh RH; Johnson JP; Avalos P; Allred P; Svendsen S; Gowing G; Roxas K; Wu A; Donahue B; Osborne S; Lawless G; Shelley B; Wheeler K; Prina C; Fine D; Kendra-Romito T; Stokes H; Manoukian V; Muthukumaran A; Garcia L; Bañuelos MG; Godoy M; Bresee C; Yu H; Drazin D; Ross L; Naruse R; Babu H; Macklin EA; Vo A; Elsayegh A; Tourtellotte W; Maya M; Burford M; Diaz F; Patil CG; Lewis RA; Svendsen CN
Nat Med; 2022 Sep; 28(9):1813-1822. PubMed ID: 36064599
[TBL] [Abstract][Full Text] [Related]
2. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
[TBL] [Abstract][Full Text] [Related]
3. GDNF delivery using human neural progenitor cells in a rat model of ALS.
Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
[TBL] [Abstract][Full Text] [Related]
4. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
[TBL] [Abstract][Full Text] [Related]
5. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
[TBL] [Abstract][Full Text] [Related]
6. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
8. Human neural progenitors differentiate into astrocytes and protect motor neurons in aging rats.
Das MM; Avalos P; Suezaki P; Godoy M; Garcia L; Chang CD; Vit JP; Shelley B; Gowing G; Svendsen CN
Exp Neurol; 2016 Jun; 280():41-9. PubMed ID: 27032721
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
[TBL] [Abstract][Full Text] [Related]
10. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
11. Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration.
Laperle AH; Moser VA; Avalos P; Lu B; Wu A; Fulton A; Ramirez S; Garcia VJ; Bell S; Ho R; Lawless G; Roxas K; Shahin S; Shelest O; Svendsen S; Wang S; Svendsen CN
Stem Cell Reports; 2023 Aug; 18(8):1629-1642. PubMed ID: 37084724
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.
Krakora D; Mulcrone P; Meyer M; Lewis C; Bernau K; Gowing G; Zimprich C; Aebischer P; Svendsen CN; Suzuki M
Mol Ther; 2013 Aug; 21(8):1602-10. PubMed ID: 23712039
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
Foust KD; Flotte TR; Reier PJ; Mandel RJ
Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
17. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
19. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats.
Gowing G; Shelley B; Staggenborg K; Hurley A; Avalos P; Victoroff J; Latter J; Garcia L; Svendsen CN
Neuroreport; 2014 Apr; 25(6):367-72. PubMed ID: 24284956
[TBL] [Abstract][Full Text] [Related]
20. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
